Point72 Middle East FZE’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-18,500
| Closed | -$31.5K | – | 448 |
|
2023
Q4 | $31.5K | Buy |
+18,500
| New | +$31.5K | ﹤0.01% | 785 |
|
2023
Q3 | – | Sell |
-67,821
| Closed | -$78.7K | – | 1124 |
|
2023
Q2 | $78.7K | Buy |
+67,821
| New | +$78.7K | ﹤0.01% | 722 |
|
2023
Q1 | – | Sell |
-14,878
| Closed | -$37.2K | – | 1315 |
|
2022
Q4 | $37.2K | Buy |
+14,878
| New | +$37.2K | ﹤0.01% | 982 |
|